Endocannabinoids and energy homeostasis: an update (Q38206159)

31 August 2017

Endocannabinoids and energy homeostasis: an update (English)

1 reference

31 August 2017

0 references

3

1 reference

31 August 2017

Luigia Cristino

1

1 reference

PubMed ID

24752980

31 August 2017

Thorsten Becker

series ordinal

2

1 reference

31 August 2017

21 April 2014

1 reference

31 August 2017

1 reference

31 August 2017

40

1 reference

31 August 2017

389-397

1 reference

31 August 2017

4

1 reference

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

31 August 2017

1 reference

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

21 January 2018

1 reference

Endocannabinoid-mediated control of synaptic transmission

21 January 2018

1 reference

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

21 January 2018

1 reference

Central nervous system control of food intake and body weight

21 January 2018

1 reference

Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice.

21 January 2018

1 reference

Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms

21 January 2018

1 reference

Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach

21 January 2018

1 reference

The intricate link between glucocorticoids and endocannabinoids at stress-relevant synapses in the hypothalamus.

21 January 2018

1 reference

Rapid synapse-specific regulation of hypothalamic magnocellular neurons by glucocorticoids

21 January 2018

1 reference

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance.

21 January 2018

1 reference

Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal.

21 January 2018

1 reference

Steroidogenic factor 1 directs programs regulating diet-induced thermogenesis and leptin action in the ventral medial hypothalamic nucleus.

21 January 2018

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release.

21 January 2018

1 reference

The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system

21 January 2018

1 reference

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

21 January 2018

1 reference

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

Bimodal control of stimulated food intake by the endocannabinoid system.

21 January 2018

1 reference

Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits

21 January 2018

1 reference

Rapid rewiring of arcuate nucleus feeding circuits by leptin.

21 January 2018

1 reference

Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons

21 January 2018

1 reference

The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release

21 January 2018

1 reference

The cannabinoid antagonist SR 141716A (Rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food.

21 January 2018

1 reference

The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol

21 January 2018

1 reference

Cannabinoid facilitation of behavioral and biochemical hedonic taste responses

21 January 2018

1 reference

CNS opioid signaling separates cannabinoid receptor 1-mediated effects on body weight and mood-related behavior in mice.

21 January 2018

1 reference

Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats

21 January 2018

1 reference

Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons.

21 January 2018

1 reference

Insulin induces long-term depression of ventral tegmental area dopamine neurons via endocannabinoids

21 January 2018

1 reference

Presynaptic leptin action suppresses excitatory synaptic transmission onto ventral tegmental area dopamine neurons.

21 January 2018

1 reference

Erk1/2 mediates leptin receptor signaling in the ventral tegmental area

21 January 2018

1 reference

Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study

21 January 2018

1 reference

Endocannabinoid signal in the gut controls dietary fat intake.

21 January 2018

1 reference

The endocannabinoid system controls food intake via olfactory processes.

21 January 2018

1 reference

The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis.

21 January 2018

1 reference

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

21 January 2018

1 reference

Cannabinoid1 receptor in the dorsal vagal complex modulates lower oesophageal sphincter relaxation in ferrets

21 January 2018

1 reference

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

21 January 2018

1 reference

Role of sex hormones in modulation of brown adipose tissue activity

21 January 2018

1 reference

Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade

21 January 2018

1 reference

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

21 January 2018

1 reference

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

21 January 2018

1 reference

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes

21 January 2018

1 reference

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats

21 January 2018

1 reference

Cannabinoid type 1 receptor mediates depot-specific effects on differentiation, inflammation and oxidative metabolism in inguinal and epididymal white adipocytes

21 January 2018

1 reference

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

21 January 2018

1 reference

Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase

21 January 2018

1 reference

The expression of receptors for endocannabinoids in human and rodent skeletal muscle.

21 January 2018

1 reference

Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle

21 January 2018

1 reference

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

21 January 2018

1 reference

Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells

21 January 2018

1 reference

Presence of functional cannabinoid receptors in human endocrine pancreas

21 January 2018

1 reference

Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells

21 January 2018

1 reference

The role of the pancreatic endocannabinoid system in glucose metabolism.

21 January 2018

1 reference

Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas

21 January 2018

1 reference

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

21 January 2018

1 reference

CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release

21 January 2018

1 reference

The CB1 antagonist rimonabant decreases insulin hypersecretion in rat pancreatic islets

21 January 2018

1 reference

Beneficial effect of a chronic treatment with rimonabant on pancreatic function and beta-cell morphology in Zucker Fatty rats.

21 January 2018

1 reference

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes

21 January 2018

1 reference

Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle

21 January 2018

1 reference

An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

21 January 2018

1 reference

2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism

21 January 2018

1 reference

Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists

21 January 2018

1 reference

Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies

21 January 2018

1 reference

The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders

21 January 2018

1 reference

Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol

21 January 2018

1 reference

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis

21 January 2018

1 reference

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects

21 January 2018

1 reference

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

21 January 2018

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIOF.1168

1 reference

31 August 2017

1 reference

PubMed ID

24752980